WELCOME TO AMPLIFY PHARMA
Amplify Pharma develops single-molecule and rationally-combined formulations for prescribers. Pharmaceutical-standard manufacturing. Doses matched to published clinical trials. Built to be detailed, not marketed.
Each product is formulated to the dose used in the underlying clinical literature, manufactured under cGMP, and supported with a prescribing dossier prepared for medical professionals.
Amplify Pharma products are intended for use under medical supervision. Clinical dossiers, product monographs, and prescribing information are available on request.
Three principles of the Amplify portfolio. Concordance, tolerability, and supra-additivity — the three determinants against which the portfolio is constructed.Therapeutic outcome in chronic prescribing is governed less by the intrinsic potency of a molecule than by three downstream conditions
1. The patient understands the prescription sufficiently to persist with it.
2. whether the molecular form is tolerated over the months required for clinical effect.
3. In combination products — whether the constituents act on convergent targets such that the combined response exceeds the sum of the parts.
Stay Informed
Get brain and heart health tips monthly